NumerixS Investment Technologies’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-3,400
Closed -$99K 362
2020
Q2
$99K Buy
3,400
+3,200
+1,600% +$88.4K 0.03% 588
2020
Q1
$5K Sell
200
-3,170
-94% -$96.9K ﹤0.01% 936
2019
Q4
$117K Sell
3,370
-1,730
-34% -$57.3K 0.02% 636
2019
Q3
$161K Buy
+5,100
New +$201K 0.04% 438

Other funds holding HCAT

NumerixS Investment Technologies's HCAT Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of Health Catalyst (HCAT) in Q3 2020, closing a stake of 3,400 shares — an estimated $99K sold.

NumerixS Investment Technologies first reported a position in HCAT in Q3 2019 and held it in 4 quarters. The position peaked at $161K in Q3 2019. 138 funds tracked by Wall St. Rank hold HCAT as of Q3 2020.

  • NumerixS Investment Technologies reported no remaining Health Catalyst position as of Q3 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 3,400 Health Catalyst shares in Q3 2020, an estimated $99K.
  • NumerixS Investment Technologies first reported a position in Health Catalyst in Q3 2019 and held it in 4 quarters.
  • NumerixS Investment Technologies's Health Catalyst position peaked at $161K in Q3 2019.
  • 138 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.